Shlomit Youst

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)

P. Wen, T. Cloughesy, N. Butowski, 2019, Neuro-oncology.